Patents by Inventor Ryusuke OMIYA

Ryusuke OMIYA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AntiPlexin A1 agonist antibody
    Patent number: 11576969
    Abstract: Provided is a novel anti-Plexin-A1 agonist antibody that promotes dendritic cell contraction. Also provided is a pharmaceutical composition comprising such an antibody and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: May 8, 2020
    Date of Patent: February 14, 2023
    Assignees: Osaka University, Chugai Seiyaku Kabushiki Kaisha
    Inventors: Atsushi Kumanogoh, Ryusuke Omiya, Hiroyuki Tsunoda, Takeshi Baba, Sachiyo Suzuki, Yuri Teranishi
  • ANTIPLEXIN A1 AGONIST ANTIBODY
    Publication number: 20200276302
    Abstract: Provided is a novel anti-Plexin-A1 agonist antibody that promotes dendritic cell contraction. Also provided is a pharmaceutical composition comprising such an antibody and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: May 8, 2020
    Publication date: September 3, 2020
    Inventors: Atsushi Kumanogoh, Ryusuke Omiya, Hiroyuki Tsunoda, Takeshi Baba, Sachiyo Suzuki, Yuri Teranishi
  • AntiPlexin A1 agonist antibody
    Patent number: 10688178
    Abstract: Provided is a novel anti-Plexin-A1 agonist antibody that promotes dendritic cell contraction. Also provided is a pharmaceutical composition comprising such an antibody and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: June 30, 2016
    Date of Patent: June 23, 2020
    Assignees: Osaka University, Chugai Seiyaku Kabushiki Kaisha
    Inventors: Atsushi Kumanogoh, Ryusuke Omiya, Hiroyuki Tsunoda, Takeshi Baba, Sachiyo Suzuki, Yuri Teranishi
  • ANTIPLEXIN A1 AGONIST ANTIBODY
    Publication number: 20180193451
    Abstract: Provided is a novel anti-Plexin-A1 agonist antibody that promotes dendritic cell contraction. Also provided is a pharmaceutical composition comprising such an antibody and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: June 30, 2016
    Publication date: July 12, 2018
    Applicants: OSAKA UNIVERSITY, CHUGAI SEIYAKU KABUSHIKI KAISHA
    Inventors: Atsushi KUMANOGOH, Ryusuke OMIYA, Hiroyuki TSUNODA, Takeshi BABA, Sachiyo SUZUKI, Yuri TERANISHI